Valuation: DarioHealth Corp.

Market Cap 71.49M 61.84M 57.75M 52.98M 99.64M 6.8B 101M 678M 266M 3.41B 268M 263M 11.27B P/E 2026 *
-1.84x
P/E 2027 * -3.76x
Enterprise Value 71.49M 61.84M 57.75M 52.98M 99.64M 6.8B 101M 678M 266M 3.41B 268M 263M 11.27B EV / Sales 2026 *
2.75x
EV / Sales 2027 * 1.92x
Free-Float
84.1%
Yield 2026 *
-
Yield 2027 * -
1 day-5.78%
1 week+0.41%
Current month+0.41%
1 month+1.11%
3 months-6.53%
6 months-26.63%
Current year-35.85%
1 week 6.19
Extreme 6.19
8.2
1 month 6.07
Extreme 6.07
8.2
Current year 5.84
Extreme 5.8445
13.64
1 year 5.84
Extreme 5.8445
17.74
3 years 5.84
Extreme 5.8445
70.8
5 years 5.84
Extreme 5.8445
387.8
10 years 5.84
Extreme 5.8445
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 11/08/2011
Chief Executive Officer 52 09/08/2013
Director of Finance/CFO 38 01/01/2021
Director TitleAgeSince
Chairman 52 23/11/2014
Director/Board Member 69 12/11/2013
Director/Board Member 57 23/11/2014
Date Insider Type Main position Quantity % Market Cap.
23/07/26 Buy

Director

14,430 0.1973%
11/09/25 Free

Director

20,000 0.0440%
11/09/25 Free

Director

20,000 0.0440%
Change 5-day change 1-year change 3-year change Capi.($)
-5.78%+0.41%-32.38%-89.45% 71.49M
-0.14%+2.00%-19.71%+2.11% 187B
+1.44%+2.07%-6.16%+5.98% 112B
-1.40%+2.93%+12.39%+72.88% 61.15B
+0.65%+3.91%+32.37%+55.21% 54.39B
-0.12%+6.79%-8.60%-37.08% 48.17B
+2.08%+1.56%+7.47%-23.09% 31.98B
+2.09%-10.31% - - 30.91B
+1.57%+3.85%+46.93%-11.45% 24.92B
+2.45%+3.97%-2.22%+5.43% 23.15B
Average +0.28%+1.35%+3.34%-2.16% 57.29B
Weighted average by Cap. +0.53%+2.02%-1.67%+10.76%

Financials

2026 *2027 *
Net sales 26.01M 22.5M 21.01M 19.28M 36.26M 2.48B 36.83M 247M 96.77M 1.24B 97.69M 95.55M 4.1B 37.33M 32.29M 30.15M 27.66M 52.03M 3.55B 52.85M 354M 139M 1.78B 140M 137M 5.89B
Net income -30.3M -26.21M -24.48M -22.45M -42.23M -2.88B -42.9M -287M -113M -1.45B -114M -111M -4.78B -14.34M -12.41M -11.59M -10.63M -19.99M -1.37B -20.31M -136M -53.36M -684M -53.86M -52.69M -2.26B
Net Debt - -
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
07/08/26 $7.300 -5.78% 29,574
06/08/26 $7.748 +1.15% 3,964
05/08/26 $7.660 +11.50% 17,082
04/08/26 $6.870 -3.24% 164,682
03/08/26 $7.100 -2.34% 9,837
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
7.300USD
Average target price
15.25USD
Spread / Average Target
+108.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRIO Stock